Announcing our newest cancer test. Screen cancer early with Onco-D-clare. Learn more

Blog

Decoding the treatment algorithm in cancer care using precision medicine

In the fight against cancer, the pursuit of personalized medicine offers hope like never before. Our founder, Dr. Ioannis Papasotiriou, is a distinguished and renowned expert in personalized cancer care. 

In our latest video, he explains how precision medicine for cancer can generate incredible results with deep collaboration between clinicians and scientists. The complexity of translating data learned from tissue and liquid biopsies into tailored treatment plans cannot be overstated. 

Without a profound partnership between the scientific and medical worlds, personalized treatment is unlikely to give the desired results. 

Watch the video to hear from Dr. Papasotiriou, and read on to learn more about how this partnership benefits you and your cancer journey.

The role of biopsies

The information extracted through biopsies, whether it is a traditional tissue biopsy or the more contemporary liquid biopsies, is crucial to further action. These diagnostic tools serve as windows into the progression and aggressiveness of the disease. 

However, the leap from freshly extracted data to personalized treatment plans is a nuanced process requiring deep expertise from the clinician who talks to the patient and the research scientist who studies the genetic material from the biopsies.

Understanding personalized cancer medicine

Cancer is an uncommon adversary. In fact, it is a diverse collection of diseases, each unique to the patient it affects. Personalized medicine in cancer care recognizes this diversity and tailors treatment strategies based on a patient's specific genetic, epigenetic, and clinical profile.

This approach recognizes that no two cancers are exactly alike, even if they originate in the same organ. At the core of precision medicine is a profound understanding of the genetic makeup of both the patient and the cancer cells. It represents a groundbreaking approach tailored to the individual characteristics of each patient and their specific type of cancer.

Within the precision medicine paradigm, we use advanced technologies, such as genetic sequencing and molecular profiling. These technologies help us learn the intricacies of a patient's DNA and the unique genetic mutations within the cancer cells. 

Unlike conventional treatments that may take a broader approach, precision medicine aims to target specific genetic aberrations driving the growth and spread of cancer. By identifying these cellular abnormalities, clinicians can apply treatments that are more likely to be effective and less likely to cause adverse effects.

This nuanced approach increases the chances of treatment success while minimizing unnecessary interventions.

Crucial questions that personalized cancer medicine helps answer:

  • How does the disease progress?
  • How aggressive is the cancer?
  • Are there resistant clones?
  • Which treatments suit the patient, considering toxicities and proper accumulation at the tumor site?

Need for collaboration between clinicians and laboratory scientists

Understanding the patient's genetic information is fundamental to the personalized medicine approach. It informs decisions about which therapies are likely to be most effective and helps predict potential side effects. 

The collaborative effort between clinicians and laboratory scientists is instrumental in deciphering this genetic code and translating it into actionable treatment strategies for the patient.

An effective treatment plan cannot be planned by your clinician in isolation. It is a collaborative process that involves the laboratory scientists who study the genetic material. At RGCC, Dr. Papasotiriou emphasizes the necessity for a seamless exchange of information between these experts.

Clinicians bring their insights into the patient's clinical status, while scientists interpret the intricate data from biopsies. It's a harmonious partnership where both the clinical and laboratory worlds contribute to forming the complete picture. 

Here’s a look at how interactions and exchange of crucial information between the two experts can help determine the best patient outcomes.

Interpreting complex data

Clinicians understand the patient's overall health, medical history, and current clinical status, explaining factors that influence the patient's well-being.

Laboratory scientists decipher complex genetic and molecular data derived from biopsies, identifying specific genetic alterations and their implications for cancer progression.

Tailoring treatment plans

Clinicians evaluate the appropriateness of various treatment options, considering factors like the patient's tolerance for specific interventions and potential side effects.

Laboratory scientists analyze genetic and molecular data to pinpoint specific aberrations driving cancer, helping to tailor treatment plans, target the genetic characteristics of the patient's cancer, and maximize efficacy.

Real-time monitoring and adjustments

Clinicians assess patient response to treatment through continuous clinical examinations and monitoring of symptoms. They can make adjustments based on the patient's overall well-being and any emerging side effects.

Laboratory scientists provide insights into the genetic and epigenetic changes occurring in cancer cells during treatment, helping to assess treatment efficacy at a genetic and epigenetic level and adapting interventions based on real-time data.

Ultimately, this collaboration forms a dynamic partnership that navigates the complexities of cancer using a nuanced and informed strategy.

Contact us

Precision medicine has transformed the landscape of cancer care. It not only acknowledges the uniqueness of each patient but also reveals the necessity for a symbiotic collaboration between clinicians and research scientists. 

Our state-of-the-art research centers employ advanced tests and protocols to offer a comprehensive yet personalized view of each patient’s genetics, physiology, and immune profiles. We offer a paradigm shift in cancer care technology and protocols.

Our mission is to empower patients with unique insights into their cancer biology, guiding them toward success in their cancer journey.

Contact us today to start your journey to empowering information for your cancer treatment by contacting us online

Follow Us
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Call
Text
Email
Map